BOOK
Miller's Anesthesia E-Book
Ronald D. Miller | Lars I. Eriksson | Lee A Fleisher | Jeanine P. Wiener-Kronish | Neal H Cohen | William L. Young
(2014)
Additional Information
Book Details
Abstract
From fundamental principles to advanced subspecialty procedures, Miller’s Anesthesia covers the full scope of contemporary anesthesia practice. This go-to medical reference book offers masterful guidance on the technical, scientific, and clinical challenges you face each day, in addition to providing the most up-to-date information available for effective board preparation.
- Consult this title on your favorite e-reader , conduct rapid searches, and adjust font sizes for optimal readability.
- Address the unique needs of pediatric patients with guidance from an entire section on pediatric anesthesia.
- View more than 1,500 full-color illustrations for enhanced visual clarity.
- Access step-by-step instructions for patient management, as well as an in-depth analysis of ancillary responsibilities and problems.
- Quickly reference important concepts with ‘Key Points’ boxes integrated into every chapter.
- Stay current on today's most recent anesthetic drugs and guidelines/protocols for anesthetic practice and patient safety, and access expanded coverage on new techniques such as TEE and other monitoring procedures.
- Take advantage of the unique, international perspectives of prominent anesthesiologists from all over the world, including the UK, Australia, India, Brazil, and Germany.
- Remain at the forefront of new developments in anesthesia with coverage of hot topics including Non-OR Anesthesia; Role of the Anesthesiologist in Disasters; Sleep Medicine in Anesthesia; Perioperative and Anesthesia-related Neurotoxicity; Anesthetic Implications of Complementary and Alternative Medicine; and Robotics.
- Study brand-new chapters on Perioperative Fluid Management; Extracorporeal Support Therapies; Anesthesia for Organ Donation/Procurement; and Malignant Hyperthermia and other Genetic Disorders.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front\rCover | Cover | ||
IFC | IFC | ||
Miller’s Anesthesia | iii | ||
Copyright | iv | ||
Dedication | v | ||
Contributors | vi | ||
Preface | xxi | ||
Remembrance | xxiii | ||
Contents | xxv | ||
Video Contents | xxx | ||
PART\rI - Introduction | 1 | ||
Chapter 1 - Scope of Modern Anesthetic Practice | 2 | ||
SCOPE OF ANESTHESIA AND PERIOPERATIVE CARE IN HEALTH CARE AND FORCES THAT WILL CHANGE PRACTICES (FIG. 1-1) | 3 | ||
PROCESS ASSESSMENT AND QUALITY METRICS | 6 | ||
CHANGES IN PERSONNEL | 7 | ||
RESEARCH | 7 | ||
References | 8 | ||
References | 9.e1 | ||
Chapter\r2 - International Scope, Practice, and Legal Aspects of Anesthesia | 10 | ||
EARLY HISTORY OF INTERNATIONAL ANESTHESIA | 12 | ||
THE CROSS-POLLINATION PERIOD: 1920-1980 | 16 | ||
THE MODERN PERIOD: THE ESSENTIALS OF MODERN ANESTHESIA AROUND THE WORLD | 21 | ||
CONCLUSION | 46 | ||
References | 46 | ||
References | 47.e1 | ||
Chapter\r3 - Perioperative Management | 48 | ||
PERIOPERATIVE MANAGEMENT | 50 | ||
CONCLUSION | 54 | ||
References | 55 | ||
References | 55.e1 | ||
Chapter\r4 - Operating Room Management | 56 | ||
HISTORY | 56 | ||
STRUCTURE FOR OPERATING ROOM MANAGEMENT | 57 | ||
OPERATING ROOM FUNCTION GOALS | 59 | ||
DAILY SCHEDULE MANAGEMENT | 65 | ||
ANESTHESIA SERVICE | 67 | ||
OPERATING ROOM QUALITY AND PATIENT SAFETY (ALSO SEE CHAPTERS 6 AND 7) | 68 | ||
COST ACCOUNTING IN THE OPERATING ROOM | 69 | ||
SUMMARY | 70 | ||
References | 71 | ||
References | 72.e1 | ||
Chapter\r5 - Medical Informatics | 73 | ||
COMPUTER HARDWARE | 74 | ||
COMPUTER SOFTWARE | 76 | ||
COMPUTERS AND COMPUTING IN MEDICINE | 80 | ||
References | 85 | ||
References | 86.e1 | ||
Chapter\r6 - Quality Improvement and Patient Safety | 87 | ||
WHAT IS QUALITY? | 88 | ||
METHODS OF QUALITY ASSESSMENT | 89 | ||
QUALITY IMPROVEMENT MEASURES AND TOOLS | 92 | ||
SOURCES OF QUALITY IMPROVEMENT INFORMATION | 96 | ||
EXAMPLES OF QUALITY IMPROVEMENT PROGRAMS | 101 | ||
THE FUTURE: RESEARCH, EDUCATION AND ETHICS | 103 | ||
SUMMARY | 104 | ||
References | 104 | ||
Reference | 105.e1 | ||
Chapter\r7 - Human Performance and Patient Safety | 106 | ||
IMPACT OF HUMAN PERFORMANCE ON PATIENT SAFETY | 106 | ||
NATURE OF THE OPERATIONAL DOMAIN OF ANESTHESIOLOGY | 107 | ||
SAFETY CULTURE OF THE OPERATING ROOM AND INTENSIVE CARE ENVIRONMENT | 108 | ||
CHARACTERISTICS OF SUCCESSFUL INCIDENT REPORTING SYSTEMS | 115 | ||
HUMAN FACTORS | 119 | ||
HOW CAN CRISIS RESOURCE MANAGEMENT SKILLS BE LEARNED AND TRAINED? | 124 | ||
THE STUDY OF HUMAN PERFORMANCE | 137 | ||
COGNITIVE PROCESS MODEL OF THE ANESTHESIA PROFESSIONAL | 138 | ||
THE ANESTHESIA PROFESSIONAL’S TASKS | 144 | ||
OTHER STUDIES OF “VIGILANCE” AND DECISION MAKING BY ANESTHESIA PROFESSIONALS | 155 | ||
References | 160 | ||
References | 166.e1 | ||
Chapter\r8 - Patient Simulation | 167 | ||
SIMULATION IN AVIATION | 168 | ||
USES OF SIMULATORS | 168 | ||
TWELVE DIMENSIONS OF SIMULATION | 168 | ||
CONCEPTUAL ISSUES ABOUT PATIENT SIMULATION | 172 | ||
SITE OF SIMULATION | 175 | ||
TEAM TRAINING, SINGLE DISCIPLINE, AND CREWS | 178 | ||
DEBRIEFING FOR SIMULATION TRAINING | 178 | ||
SCENARIO DESIGN | 181 | ||
INSTRUCTOR QUALIFICATION | 181 | ||
CLASSIFICATION OF PATIENT SIMULATORS | 184 | ||
DEVELOPMENT OF PATIENT SIMULATORS | 188 | ||
SCREEN-BASED SIMULATORS (MICROSIMULATORS) | 188 | ||
EXPERIENCE WITH PATIENT SIMULATORS IN ANESTHESIA | 188 | ||
USE OF PATIENT SIMULATION FOR TRAINING HEALTH CARE PERSONNEL OUTSIDE ANESTHESIA | 193 | ||
USE OF PATIENT SIMULATION FOR RESEARCH | 194 | ||
USE OF PATIENT SIMULATION IN SUPPORT OF BIOMEDICAL INDUSTRIES | 196 | ||
OTHER USES OF SIMULATORS | 196 | ||
EFFECTIVENESS OF SIMULATION TRAINING | 196 | ||
ECOLOGIC VALIDITY OF SIMULATORS COMPARED WITH THE OPERATING ROOM | 198 | ||
EVALUATION OF CLINICAL PERFORMANCE DURING SIMULATION SCENARIOS | 198 | ||
PITFALLS OF PERFORMANCE ASSESSMENT | 199 | ||
USE OF SIMULATORS FOR THE EVALUATION AND TESTING OF ANESTHESIA PROFESSIONALS | 200 | ||
COSTS | 203 | ||
PROLIFERATION OF SIMULATION CENTERS | 203 | ||
SIMULATION SOCIETIES: SOCIETY FOR SIMULATION IN HEALTH CARE AND SOCIETY IN EUROPE FOR SIMULATION APPLIED TO MEDICINE | 205 | ||
FUTURE OF PATIENT SIMULATION IN ANESTHESIA | 205 | ||
References | 206 | ||
References | 209.e1 | ||
Chapter\r9 - Teaching Anesthesia | 210 | ||
BACKGROUND AND HISTORY OF ANESTHESIA EDUCATION (ALSO SEE CHAPTER 1) | 211 | ||
ANESTHESIA LEARNERS | 213 | ||
RESIDENT AND FELLOW EDUCATION | 215 | ||
ANESTHESIA TEACHING METHODS | 223 | ||
THE FUTURE OF ANESTHESIA EDUCATION | 227 | ||
References | 228 | ||
References | 231.e1 | ||
Chapter\r10 - Ethical Aspects of Anesthesia Care | 232 | ||
ETHICAL THEORY | 235 | ||
CLINICAL ETHICS | 236 | ||
RESEARCH ETHICS | 246 | ||
PHYSICIAN PARTICIPATION IN EXECUTIONS | 248 | ||
MORAL INTEGRITY—CAN THE PHYSICIAN BE A CONSCIENTIOUS OBJECTOR IN MEDICINE? | 248 | ||
SUMMARY | 249 | ||
References | 249 | ||
References | 250.e1 | ||
Chapter\r11 - Legal Aspects of Anesthesia Care in America | 251 | ||
PROFESSIONAL LIABILITY | 252 | ||
LEGAL ASPECTS OF INFORMED CONSENT | 257 | ||
LEGAL ASPECTS OF END-OF-LIFE CARE | 260 | ||
OTHER LEGAL ASPECTS OF ANESTHESIOLOGY | 263 | ||
References | 266 | ||
References | 267.e1 | ||
Chapter\r12 - Anesthesia Business Models | 268 | ||
PRACTICE MODELS | 269 | ||
STAFFING MODELS | 271 | ||
ESSENTIAL BUSINESS PRACTICES | 274 | ||
References | 278 | ||
References | 280.e1 | ||
PART\rII - Anesthetic Physiology | 281 | ||
Chapter\r13 - Consciousness, Memory, and Anesthesia | 282 | ||
SCIENTIFIC AND CLINICAL IMPORTANCE | 282 | ||
CONSCIOUSNESS | 282 | ||
MEMORY | 289 | ||
CONCLUSION | 300 | ||
References | 300 | ||
References | 302.e1 | ||
Chapter\r14 - Sleep Medicine | 303 | ||
DEFINITION OF SLEEP | 303 | ||
HOW TO ASSESS SLEEP | 304 | ||
PHYSIOLOGY | 308 | ||
SLEEP AND BREATHING | 312 | ||
SLEEP AND ANESTHESIA: TWO UNEQUAL TWINS INFLUENCING PERIOPERATIVE MEDICINE | 319 | ||
References | 326 | ||
References | 328.e1 | ||
Chapter\r15 - Perioperative and Anesthesia Neurotoxicity | 329 | ||
DEVELOPMENTAL NEUROTOXICITY | 329 | ||
NEUROTOXICITY IN THE ELDERLY | 337 | ||
SUMMARY AND CONCLUSIONS | 343 | ||
References | 344 | ||
References | 345.e1 | ||
Chapter\r16 - The Autonomic Nervous System | 346 | ||
HISTORY AND DEFINITIONS | 346 | ||
FUNCTIONAL ANATOMY | 347 | ||
FUNCTION | 351 | ||
PHARMACOLOGY | 355 | ||
DRUGS AND THE AUTONOMIC NERVOUS SYSTEM | 365 | ||
AUTONOMIC DYSFUNCTION | 379 | ||
NEW CONCEPTS IN AUTONOMIC ACTIVITY | 383 | ||
References | 383 | ||
References | 386.e1 | ||
Chapter\r17 - Cerebral Physiology and the Effects of Anesthetic Drugs | 387 | ||
ANATOMY OF THE CEREBRAL CIRCULATION | 388 | ||
EFFECTS OF ANESTHETICS ON CEREBRAL BLOOD FLOW AND CEREBRAL METABOLIC RATE | 396 | ||
OTHER EFFECTS OF ANESTHETICS ON CEREBRAL PHYSIOLOGY | 408 | ||
CEREBRAL PHYSIOLOGY IN PATHOLOGIC STATES | 410 | ||
References | 419 | ||
References | 422.e1 | ||
Chapter\r18 - Neuromuscular Physiology and Pharmacology | 423 | ||
NEUROMUSCULAR TRANSMISSION | 425 | ||
NEUROMUSCULAR JUNCTION | 428 | ||
DRUG EFFECTS ON POSTJUNCTIONAL RECEPTORS | 433 | ||
BIOLOGY OF PREJUNCTIONAL AND POSTJUNCTIONAL NICOTINIC ACETYLCHOLINE RECEPTORS | 437 | ||
NEUROMUSCULAR JUNCTION AT EXTREMES OF AGE | 442 | ||
References | 443 | ||
References | 443.e1 | ||
Chapter\r19 - Respiratory Physiology and Pathophysiology | 444 | ||
RESPIRATORY PHYSIOLOGY IS CENTRAL TO THE PRACTICE OF ANESTHESIA | 444 | ||
PULMONARY PHYSIOLOGY IN HEALTH | 444 | ||
VENTILATION | 446 | ||
STATIC LUNG VOLUMES—FUNCTIONAL RESIDUAL CAPACITY | 447 | ||
RESPIRATORY MECHANICS | 447 | ||
DISTRIBUTION OF INSPIRED GAS | 451 | ||
PERFUSION | 453 | ||
CLINICAL ASSESSMENT OF LUNG FUNCTION | 455 | ||
INTRAOPERATIVE RESPIRATORY EVENTS | 456 | ||
VENTILATION-PERFUSION MATCHING DURING ANESTHESIA | 462 | ||
FACTORS THAT INFLUENCE RESPIRATORY FUNCTION DURING ANESTHESIA | 464 | ||
LUNG FUNCTION AFTER CARDIAC SURGERY | 470 | ||
POSTOPERATIVE PHYSIOTHERAPY | 471 | ||
EFFECT OF SLEEP ON RESPIRATION | 471 | ||
References | 471 | ||
References | 472.e1 | ||
Chapter\r20 - Cardiac Physiology | 473 | ||
PHYSIOLOGY OF THE INTACT HEART | 473 | ||
CELLULAR CARDIAC PHYSIOLOGY | 479 | ||
CONTROL OF CARDIAC FUNCTION | 485 | ||
References | 490 | ||
References | 491.e1 | ||
Chapter\r21 - Gastrointestinal Physiology and Pathophysiology | 492 | ||
REGULATION OF GASTROINTESTINAL FUNCTION | 493 | ||
INTESTINAL MUCOSAL IMMUNOLOGY | 493 | ||
NEUROCRINE REGULATION OF MOTILITY | 494 | ||
TRAVEL AND MIXING OF FOOD IN THE GASTROINTESTINAL TRACT | 495 | ||
SECRETION | 500 | ||
DIGESTION AND ABSORPTION | 505 | ||
GASTROINTESTINAL BLOOD FLOW | 509 | ||
SPLANCHNIC BLOOD VOLUME | 511 | ||
References | 518 | ||
References | 519.e1 | ||
Chapter\r22 - Hepatic Physiology and Pathophysiology | 520 | ||
OVERVIEW | 521 | ||
HEPATIC ANATOMY | 521 | ||
FUNCTIONS OF THE LIVER | 525 | ||
EVALUATION OF THE LIVER | 531 | ||
HEPATIC PATHOPHYSIOLOGY | 535 | ||
References | 542 | ||
References | 544.e1 | ||
Chapter\r23 - Renal Physiology, Pathophysiology, and Pharmacology | 545 | ||
THE GLOMERULUS (RENAL CORPUSCLE) | 547 | ||
THE TUBULE | 550 | ||
REGULATORY MECHANISMS IN SALT AND WATER REABSORPTION | 555 | ||
EVALUATION OF RENAL FUNCTION | 556 | ||
ASSESSMENT OF GLOMERULAR FILTRATION RATE | 558 | ||
TUBULAR FUNCTION TESTS | 561 | ||
RENAL HEMODYNAMICS | 564 | ||
NEUROHORMONAL REGULATION OF RENAL FUNCTION | 566 | ||
SYSTEMS PROMOTING VASOCONSTRICTION AND SALT RETENTION | 566 | ||
Systems Promoting Vasodilation and Salt Excretion | 570 | ||
PROSTAGLANDINS AND KININS | 570 | ||
PERIOPERATIVE ISCHEMIC AND NEPHROTOXIC INJURY | 574 | ||
ANESTHETIC DRUGS | 574 | ||
MECHANICAL VENTILATION | 576 | ||
INDUCED HYPOTENSION | 576 | ||
AORTIC CROSS-CLAMPING | 576 | ||
CARDIAC SURGERY AND CARDIOPULMONARY BYPASS | 577 | ||
NEPHROTOXIC INSULTS | 580 | ||
SEPSIS | 582 | ||
RENAL CROSSTALK | 585 | ||
References | 585 | ||
References | 588.e1 | ||
PART III -\rAnesthetic Pharmacology | 589 | ||
Chapter\r24 - Basic Principles of Pharmacology | 590 | ||
PHARMACOKINETICS PRINCIPLES | 591 | ||
PHARMACODYNAMIC PRINCIPLES | 600 | ||
SPECIAL POPULATIONS | 605 | ||
SUMMARY | 612 | ||
References | 612 | ||
References | 613.e1 | ||
Chapter 25\r- Inhaled Anesthetics: Mechanisms of Action | 614 | ||
HISTORY | 615 | ||
INTEGRATED EFFECTS ON CENTRAL NERVOUS SYSTEM FUNCTION | 618 | ||
IDENTIFICATION OF MOLECULAR SITES OF ANESTHETIC ACTION | 623 | ||
CELLULAR MECHANISMS | 629 | ||
SIMPLE CIRCUITS AND COMPLEX NETWORKS | 631 | ||
RESEARCH STRATEGIES FOR THE FUTURE | 633 | ||
SUMMARY | 635 | ||
References | 635 | ||
References | 637.e1 | ||
Chapter\r26 - Inhaled Anesthetic Pharmacokinetics: Uptake, Distribution, Metabolism, and Toxicity | 638 | ||
INTRODUCTION | 639 | ||
UPTAKE AND DISTRIBUTION OF INHALED ANESTHETICS | 639 | ||
SYNTHESIS OF THE MODEL AND INHALED ANESTHETIC INDUCTION: PK/PD | 650 | ||
METABOLISM AND TOXICITY OF INHALED ANESTHETICS | 656 | ||
References | 667 | ||
References | 669.e1 | ||
Chapter\r27 - Inhaled Anesthetics: Pulmonary Pharmacology | 670 | ||
INTRODUCTION | 671 | ||
INHALED ANESTHETICS | 671 | ||
CONTROL OF RESPIRATION | 687 | ||
ACUTE LUNG INJURY | 698 | ||
NITROUS OXIDE | 702 | ||
XENON | 702 | ||
SUMMARY | 702 | ||
References | 703 | ||
References | 705.e1 | ||
Chapter\r28 - Inhaled Anesthetics: Cardiovascular Pharmacology | 706 | ||
INTRODUCTION | 706 | ||
VOLATILE ANESTHETICS | 706 | ||
NITROUS OXIDE AND CARDIOVASCULAR FUNCTION | 742 | ||
XENON | 744 | ||
SUMMARY | 748 | ||
References | 749 | ||
References | 751.e1 | ||
Chapter\r29 - Inhaled Anesthetics: Delivery Systems | 752 | ||
STANDARDS AND GUIDELINES FOR ANESTHESIA WORKSTATIONS | 754 | ||
FUNCTIONAL ANATOMY OF THE ANESTHESIA WORKSTATION | 755 | ||
CHECKING YOUR ANESTHESIA WORKSTATION | 804 | ||
References | 817 | ||
References | 820.e1 | ||
Chapter\r30 - Intravenous Anesthetics | 821 | ||
PROPOFOL | 822 | ||
BARBITURATES | 832 | ||
BENZODIAZEPINES | 837 | ||
FLUMAZENIL | 843 | ||
PHENCYCLIDINES (KETAMINE) | 845 | ||
ETOMIDATE | 850 | ||
DEXMEDETOMIDINE | 854 | ||
DROPERIDOL | 859 | ||
SUMMARY | 860 | ||
References | 860 | ||
Refernces | 863.e1 | ||
Chapter\r31 - Opioid Analgesics | 864 | ||
PHARMACOLOGY OF OPIOIDS | 864 | ||
NEUROPHYSIOLOGIC EFFECTS OF OPIOIDS | 873 | ||
RESPIRATORY EFFECTS OF OPIOIDS | 877 | ||
CARDIOVASCULAR EFFECTS OF OPIOIDS | 879 | ||
ENDOCRINOLOGIC EFFECTS OF OPIOIDS | 881 | ||
OPIOID TOLERANCE AND OPIOID-INDUCED HYPERALGESIA | 882 | ||
RENAL AND URODYNAMIC EFFECTS OF OPIOIDS | 883 | ||
GASTROINTESTINAL EFFECTS OF OPIOIDS | 884 | ||
OTHER OPIOID EFFECTS | 885 | ||
PHARMACOKINETICS AND PHARMACODYNAMICS OF OPIOIDS | 886 | ||
ANESTHETIC TECHNIQUES USING OPIOIDS | 894 | ||
OTHER OPIOID AGONISTS | 901 | ||
AGONIST-ANTAGONIST OPIOID COMPOUNDS | 903 | ||
OPIOID ANTAGONISTS | 906 | ||
DRUG INTERACTONS WITH OPIOIDS | 907 | ||
References | 910 | ||
References | 914.e1 | ||
Chapter\r32 - Nonopioid Pain Medications | 915 | ||
INTRODUCTION | 915 | ||
CALCIUM CHANNEL BLOCKERS | 915 | ||
SODIUM CHANNEL BLOCKERS | 917 | ||
References | 918 | ||
References | 918.e1 | ||
Chapter 33 - Intravenous Drug Delivery Systems | 919 | ||
INTRODUCTION | 920 | ||
PHARMACOKINETIC CONSIDERATIONS | 921 | ||
PHARMACODYNAMIC CONSIDERATIONS | 925 | ||
DESIGNING DOSING REGIMENS | 934 | ||
INTRAVENOUS INFUSION DEVICES AND TECHNOLOGIES | 942 | ||
References | 956 | ||
References | 957.e1 | ||
Chapter\r34 - Pharmacology of Neuromuscular Blocking Drugs | 958 | ||
HISTORY AND CLINICAL USE | 959 | ||
PRINCIPLES OF ACTION OF NEUROMUSCULAR BLOCKERS AT THE NEUROMUSCULAR JUNCTION | 959 | ||
PHARMACOLOGY OF SUCCINYLCHOLINE | 960 | ||
NONDEPOLARIZING NEUROMUSCULAR BLOCKERS | 965 | ||
SPECIAL POPULATIONS | 983 | ||
References | 992 | ||
References | 994.e1 | ||
Chapter\r35 - Reversal (Antagonism) of Neuromuscular Blockade | 995 | ||
HISTORY | 996 | ||
ANTAGONISM OF NEUROMUSCULAR BLOCKADE: CURRENT MANAGEMENT PRACTICES | 996 | ||
DRUGS USED TO ANTAGONIZE (REVERSE) NEUROMUSCULAR BLOCKADE | 1004 | ||
References | 1025 | ||
References | 1027.e1 | ||
Chapter\r36 - Local Anesthetics | 1028 | ||
BASIC PHARMACOLOGY | 1029 | ||
ANATOMY OF THE PERIPHERAL NERVE | 1031 | ||
MECHANISM OF ACTION OF LOCAL ANESTHETICS (PHARMACODYNAMICS) | 1035 | ||
CLINICAL PHARMACOLOGY | 1038 | ||
CHOICE OF LOCAL ANESTHETIC FOR VARIOUS REGIONAL ANESTHETIC PROCEDURES | 1041 | ||
PHARMACOKINETICS | 1046 | ||
TOXICITY | 1047 | ||
DEVELOPMENT OF PROLONGED-DURATION AND SENSORY- OR NOCICEPTIVE-SELECTIVE LOCAL ANESTHETICS | 1051 | ||
BIOLOGIC MECHANISMS OF LOCAL ANESTHETIC FAILURE: INFLAMMATION, HYPERALGESIA, TACHYPHYLAXIS, AND GENETIC VARIANTS | 1051 | ||
References | 1052 | ||
References | 1054.e1 | ||
PART IV -\rAnesthesia Management | 1055 | ||
Chapter\r37 - Risk of Anesthesia | 1056 | ||
INTRODUCTION | 1056 | ||
FRAMEWORK OF PERIOPERATIVE RISK | 1057 | ||
ISSUES RELATED TO STUDY DESIGN | 1058 | ||
RISKS RELATED TO PATIENT CHARACTERISTICS | 1070 | ||
SPECIAL PATIENT GROUPS | 1073 | ||
RISKS DIRECTLY RELATED TO THE ANESTHETIC DRUG | 1077 | ||
RISKS RELATED TO SURGERY | 1078 | ||
RISKS RELATED TO THE LOCATION OF SURGERY AND POSTOPERATIVE MONITORING | 1078 | ||
RISKS RELATED TO THE ANESTHESIA PROVIDER | 1079 | ||
RISKS TO THE ANESTHESIOLOGIST | 1080 | ||
IMPROVING ANESTHESIA SAFETY | 1081 | ||
SUMMARY | 1082 | ||
References | 1082 | ||
References | 1084.e1 | ||
Chapter\r38 - Preoperative Evaluation | 1085 | ||
EVOLUTION OF PREANESTHESIA EVALUATION | 1086 | ||
GOALS AND BENEFITS OF PREANESTHESIA EVALUATION | 1086 | ||
ROLE OF THE MEDICAL CONSULTANT IN PREOPERATIVE EVALUATION | 1087 | ||
DETECTING DISEASE IN PREOPERATIVE EVALUATION | 1088 | ||
PREOPERATIVE EVALUATION OF PATIENTS WITH COEXISTING DISEASE | 1092 | ||
SPECIAL ISSUES IN PREOPERATIVE EVALUATION | 1135 | ||
PREOPERATIVE LABORATORY AND DIAGNOSTIC STUDIES | 1141 | ||
PREOPERATIVE RISK ASSESSMENT | 1144 | ||
PREOPERATIVE MEDICATION MANAGEMENT | 1146 | ||
PLANNING FOR ANESTHESIA | 1147 | ||
REGULATORY ISSUES | 1149 | ||
PREOPERATIVE EVALUATION CLINIC | 1149 | ||
CONCLUSION | 1152 | ||
References | 1153 | ||
References | 1155.e1 | ||
Chapter\r39 - Anesthetic Implications of Concurrent Diseases | 1156 | ||
ROLE OF THE PRIMARY CARE PHYSICIAN OR CONSULTANT | 1157 | ||
DISEASES INVOLVING THE ENDOCRINE SYSTEM AND DISORDERS OF NUTRITION | 1158 | ||
DISEASES INVOLVING THE CARDIOVASCULAR SYSTEM | 1181 | ||
DISORDERS OF THE RESPIRATORY AND IMMUNE SYSTEMS | 1190 | ||
DISEASES OF THE CENTRAL NERVOUS SYSTEM, NEUROMUSCULAR DISEASES, AND PSYCHIATRIC DISORDERS | 1196 | ||
RENAL DISEASE AND ELECTROLYTE DISORDERS | 1202 | ||
GASTROINTESTINAL AND LIVER DISEASES | 1208 | ||
HEMATOLOGIC DISORDERS AND ONCOLOGIC DISEASE | 1211 | ||
PATIENTS GIVEN DRUG THERAPY FOR CHRONIC AND ACUTE MEDICAL CONDITIONS | 1217 | ||
References | 1222 | ||
References | 1225.e1 | ||
Chapter\r40 - Anesthetic Implications of Complementary and Alternative Medications | 1226 | ||
HERBAL MEDICINES | 1227 | ||
SUMMARY | 1235 | ||
ACUPUNCTURE | 1235 | ||
DEEP BREATHING | 1236 | ||
MUSIC THERAPY | 1236 | ||
CONCLUSION | 1237 | ||
References | 1237 | ||
References | 1239.e1 | ||
Chapter\r41 - Patient Positioning and Associated Risks | 1240 | ||
INTRODUCTION | 1240 | ||
CARDIOVASCULAR CONCERNS | 1241 | ||
PULMONARY CONCERNS | 1241 | ||
SPECIFIC POSITIONS | 1242 | ||
PERIPHERAL NERVE INJURY | 1256 | ||
SPECIFIC NEUROPATHIES | 1258 | ||
PERIOPERATIVE EYE INJURY AND VISUAL LOSS | 1261 | ||
EVALUATION AND TREATMENT OF PERIOPERATIVE NEUROPATHIES | 1262 | ||
ANESTHESIA OUTSIDE THE OPERATING ROOM | 1263 | ||
CONCLUSION | 1264 | ||
References | 1264 | ||
References | 1265.e1 | ||
Chapter\r42 - Neuromuscular Disorders and Other Genetic Disorders | 1266 | ||
ACQUIRED AND HEREDITARY NEUROPATHIES | 1267 | ||
GUILLAIN-BARRÉ SYNDROME OR ACUTE INFLAMMATORY DEMYELINATING POLYRADICULOPATHY | 1269 | ||
CRITICAL ILLNESS POLYNEUROPATHY AND CRITICAL ILLNESS MYOPATHY | 1269 | ||
MYASTHENIA GRAVIS | 1270 | ||
LAMBERT-EATON-MYASTHENIC SYNDROME | 1271 | ||
MULTIPLE SCLEROSIS | 1271 | ||
AMYOTROPHIC LATERAL SCLEROSIS | 1272 | ||
DUCHENNE MUSCULAR DYSTROPHY | 1273 | ||
BECKER MUSCULAR DYSTROPHY | 1275 | ||
LIMB-GIRDLE MUSCULAR DYSTROPHY | 1275 | ||
MYOTONIC DYSTROPHIES | 1276 | ||
MYOTUBULAR OR CENTRONUCLEAR MYOPATHY | 1276 | ||
DISORDERS OF MUSCLE ENERGY METABOLISM | 1277 | ||
MITOCHONDRIAL MYOPATHIES | 1278 | ||
PERIODIC PARALYSES | 1279 | ||
HYPOKALEMIC PERIODIC PARALYSIS | 1280 | ||
GENETICS OF MENDELIAN, MITOCHONDRIAL, AND COMPLEX DISEASES | 1281 | ||
MITOCHONDRIAL DISEASES | 1281 | ||
IMPLICATIONS FOR CLINICAL TRANSLATION | 1283 | ||
IMPLICATION FOR ANESTHESIOLOGISTS | 1283 | ||
References | 1284 | ||
References | 1286.e1 | ||
Chapter\r43 - Malignant Hyperthermia and Muscle-Related Disorders | 1287 | ||
MALIGNANT HYPERTHERMIA | 1288 | ||
MALIGNANT HYPERTHERMIA IS THE RESULT OF ABNORMAL FUNCTION OF MUSCLE CALCIUM RELEASE UNITS | 1290 | ||
DANTROLENE | 1291 | ||
GENETICS | 1292 | ||
FULMINANT MALIGNANT HYPERTHERMIA | 1294 | ||
ANESTHETIC TRIGGERING | 1294 | ||
NONANESTHETIC MALIGNANT HYPERTHERMIA | 1295 | ||
MALIGNANT HYPERTHERMIA–ASSOCIATED SYNDROMES | 1296 | ||
DIAGNOSIS IN THE SURGICAL AND POSTANESTHESIA CARE UNITS | 1297 | ||
TREATMENT | 1298 | ||
ANESTHESIA FOR SUSCEPTIBLE PATIENTS | 1299 | ||
EVALUATION OF SUSCEPTIBILITY | 1299 | ||
MULTIPLE SCLEROSIS | 1300 | ||
MOTOR NEURON DISORDERS | 1300 | ||
GUILLAIN-BARRÉ SYNDROME | 1301 | ||
HEREDITARY MOTOR-SENSORY NEUROPATHIES, INCLUDING CHARCOT-MARIE-TOOTH DISEASE | 1301 | ||
DUCHENNE MUSCULAR DYSTROPHY AND BECKER MUSCULAR DYSTROPHY | 1302 | ||
LIMB-GIRDLE MUSCULAR DYSTROPHY | 1305 | ||
MYOTONIC DYSTROPHY | 1305 | ||
MYOTONIA CONGENITA | 1306 | ||
MYOTUBULAR MYOPATHY | 1306 | ||
METABOLIC MYOPATHIES | 1306 | ||
MITOCHONDRIAL MYOPATHIES | 1308 | ||
MYASTHENIA GRAVIS | 1309 | ||
EATON-LAMBERT MYASTHENIC SYNDROME | 1310 | ||
PERIODIC PARALYSIS (HYPERKALEMIC, HYPOKALEMIC, AND NORMOKALEMIC) | 1310 | ||
SUMMARY | 1311 | ||
References | 1311 | ||
References | 1314.e1 | ||
Chapter\r44 - Fundamental Principles of Monitoring Instrumentation | 1315 | ||
WHY FUNDAMENTAL PRINCIPLES ARE IMPORTANT | 1315 | ||
BASIC PRINCIPLES | 1315 | ||
MEASUREMENT USING LIGHT ENERGY | 1331 | ||
SIGNAL ARTIFACT MANAGEMENT | 1334 | ||
MEASUREMENT OF TEMPERATURE | 1335 | ||
MEASUREMENT OF FLOW | 1336 | ||
References | 1339 | ||
References | 1344.e1 | ||
Chapter\r45 - Cardiovascular Monitoring | 1345 | ||
INTRODUCTION TO CARDIOVASCULAR MONITORING: FOCUSED PHYSICAL EXAMINATION | 1346 | ||
ARTERIAL BLOOD PRESSURE MONITORING | 1347 | ||
CENTRAL VENOUS PRESSURE MONITORING | 1361 | ||
PULMONARY ARTERY CATHETER MONITORING | 1370 | ||
CARDIAC OUTPUT MONITORING | 1387 | ||
OTHER METHODS FOR MONITORING CARDIAC OUTPUT AND PERFUSION | 1389 | ||
References | 1392 | ||
References | 1395.e1 | ||
Chapter\r46 - Perioperative Echocardiography | 1396 | ||
INTRODUCTION | 1396 | ||
HISTORY | 1396 | ||
TRANSESOPHAGEAL ECHOCARDIOGRAPHY PRACTICE GUIDELINES | 1397 | ||
PROPERTIES OF ULTRASOUND | 1398 | ||
EQUIPMENT DESIGN AND OPERATION | 1405 | ||
BASIC TRANSESOPHAGEAL ECHOCARDIOGRAPHIC EXAMINATION | 1410 | ||
COMPREHENSIVE TRANSESOPHAGEAL EXAMINATION | 1412 | ||
BASIC TRANSTHORACIC EXAMINATION | 1414 | ||
ASSESSMENT OF VENTRICULAR FILLING | 1416 | ||
DETECTION OF MYOCARDIAL ISCHEMIA | 1420 | ||
TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN CARDIAC SURGERY | 1421 | ||
TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN NONCARDIAC SURGERY AND CRITICAL CARE | 1427 | ||
DATA STORAGE, DOCUMENTATION, AND QUALITY ASSURANCE | 1427 | ||
CERTIFICATION | 1427 | ||
References | 1428 | ||
References | 1428.e1 | ||
Chapter\r47 - Electrocardiography, Perioperative Ischemia, and Myocardial Infarction | 1429 | ||
ELECTROCARDIOGRAPHIC LEAD SYSTEMS | 1430 | ||
NORMAL ELECTRICAL ACTIVITY | 1430 | ||
THE ABNORMAL ELECTROCARDIOGRAM | 1431 | ||
ELECTROCARDIOGRAPHIC MONITORING SYSTEMS | 1434 | ||
ARRHYTHMIA INTERPRETATION AND MANAGEMENT | 1437 | ||
REAL-TIME MYOCARDIAL ISCHEMIA MONITORING | 1449 | ||
ELECTROCARDIOGRAPHIC CRITERIA FOR ACUTE MYOCARDIAL ISCHEMIA | 1450 | ||
ELECTROCARDIOGRAPHIC LEAD SENSITIVITY FOR DETECTING PERIOPERATIVE MYOCARDIAL ISCHEMIA | 1451 | ||
PERIOPERATIVE MYOCARDIAL ISCHEMIA AND INFARCTION | 1451 | ||
References | 1459 | ||
References | 1459.e1 | ||
Chapter\r48 - Implantable Cardiac Pulse Generators: Pacemakers and Cardioverter-Defibrillators | 1460 | ||
PACEMAKERS | 1464 | ||
IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS | 1476 | ||
SPECIAL SITUATIONS: VENTRICULAR ASSIST DEVICES AND TEMPORARY PACING | 1482 | ||
SUMMARY | 1483 | ||
References | 1485 | ||
References | 1486.e1 | ||
Chapter\r49 - Neurologic Monitoring | 1487 | ||
MONITORING MODALITIES | 1488 | ||
CLINICAL APPLICATIONS OF NEUROLOGIC MONITORING | 1501 | ||
NONSURGICAL FACTORS INFLUENCING MONITORING RESULTS | 1511 | ||
SUMMARY | 1521 | ||
References | 1521 | ||
References | 1523.e1 | ||
Chapter\r50 - Monitoring Brain State During General Anesthesia and Sedation | 1524 | ||
INDUCTION OF GENERAL ANESTHESIA | 1525 | ||
MAINTENANCE OF GENERAL ANESTHESIA: PHYSIOLOGIC SIGNS AND THE NOCICEPTIVE-MEDULLARY-AUTONOMIC PATHWAY | 1525 | ||
MAINTENANCE OF GENERAL ANESTHESIA: ELECTROENCEPHALOGRAM-BASED INDICES OF LEVEL OF CONSCIOUSNESS | 1527 | ||
EMERGENCE FROM GENERAL ANESTHESIA | 1531 | ||
EMERGING STRATEGIES FOR MONITORING THE BRAIN STATES OF GENERAL ANESTHESIA AND SEDATION | 1533 | ||
References | 1539 | ||
References | 1540.e1 | ||
Chapter\r51 - Respiratory Monitoring | 1541 | ||
OVERVIEW OF RESPIRATORY MONITORING | 1542 | ||
AMERICAN SOCIETY OF ANESTHESIOLOGISTS STANDARDS | 1543 | ||
PHYSICAL EXAMINATION | 1543 | ||
PULSE OXIMETRY | 1544 | ||
MIXED VENOUS OXYGEN SATURATION | 1548 | ||
TISSUE OXYGENATION | 1549 | ||
CAPNOMETRY AND CAPNOGRAPHY | 1551 | ||
BLOOD GAS ANALYSIS | 1553 | ||
MONITORING LUNG FLOWS, VOLUMES, AND PRESSURES | 1559 | ||
PLETHYSMOGRAPHIC MONITORING | 1566 | ||
RESPIRATORY RATE MONITORING: APNEA MONITORING | 1567 | ||
IMAGING FOR RESPIRATORY MONITORING | 1568 | ||
POINT-OF-CARE TESTS | 1571 | ||
RESPIRATORY MONITORING IN SPECIAL CONDITIONS | 1572 | ||
AUTOMATED DATA SYSTEMS | 1573 | ||
ADDITIONAL MONITORED VARIABLES | 1574 | ||
References | 1576 | ||
References | 1579.e1 | ||
Chapter\r52 - Renal Function Monitoring | 1580 | ||
RENAL PHYSIOLOGIC FUNCTION | 1581 | ||
PATHOPHYSIOLOGIC PROCESSES OF ISCHEMIC ACUTE KIDNEY INJURY | 1585 | ||
ANESTHESIA, SURGERY, AND NORMAL RENAL FUNCTION | 1587 | ||
PERIOPERATIVE HEMODYNAMIC INSTABILITY AND RENAL FUNCTION | 1589 | ||
OTHER PERIOPERATIVE PERTURBATIONS AND RENAL FUNCTION | 1589 | ||
MONITORS OF RENAL FUNCTION | 1591 | ||
INDIRECT MARKERS OF OPTIMAL RENAL PERFUSION AND FUNCTION | 1591 | ||
AUTOREGULATION AND DISTRIBUTION OF CARDIAC OUTPUT TO THE KIDNEYS | 1593 | ||
EXCESSIVE INTRAVASCULAR VOLUME AND THE ABDOMINAL COMPARTMENT SYNDROME | 1594 | ||
LABORATORY TESTS OF SERUM AND URINE AS MARKERS OF RENAL FUNCTION | 1594 | ||
NOVEL (EARLY) BIOMARKERS OF ACUTE KIDNEY INJURY | 1599 | ||
PREOPERATIVE EVALUATION OF RENAL FUNCTION | 1601 | ||
SUMMARY | 1601 | ||
References | 1601 | ||
References | 1603.e1 | ||
Chapter\r53 - Neuromuscular Monitoring | 1604 | ||
TYPES OF PERIPHERAL NERVE STIMULATION | 1605 | ||
PRINCIPLES OF PERIPHERAL NERVE STIMULATION | 1605 | ||
PATTERNS OF NERVE STIMULATION | 1605 | ||
THE NERVE STIMULATOR | 1609 | ||
STIMULATING ELECTRODES | 1609 | ||
SITES OF NERVE STIMULATION AND DIFFERENT MUSCLE RESPONSES | 1610 | ||
RECORDING OF EVOKED RESPONSES | 1611 | ||
EVALUATION OF RECORDED EVOKED RESPONSES | 1614 | ||
USE OF NERVE STIMULATORS IN DAILY CLINICAL PRACTICE | 1617 | ||
WHEN TO USE A PERIPHERAL NERVE STIMULATOR | 1619 | ||
References | 1621 | ||
References | 1621.e1 | ||
Chapter\r54 - Temperature Regulation and Monitoring | 1622 | ||
NORMAL THERMOREGULATION | 1622 | ||
THERMOREGULATION DURING GENERAL ANESTHESIA | 1624 | ||
DEVELOPMENT OF HYPOTHERMIA DURING GENERAL ANESTHESIA | 1627 | ||
NEURAXIAL ANESTHESIA | 1628 | ||
CONSEQUENCES OF MILD INTRAOPERATIVE HYPOTHERMIA | 1631 | ||
PERIOPERATIVE THERMAL MANIPULATIONS | 1636 | ||
DELIBERATE SEVERE INTRAOPERATIVE HYPOTHERMIA | 1639 | ||
HYPERTHERMIA AND FEVER | 1640 | ||
TEMPERATURE MONITORING | 1642 | ||
TEMPERATURE MONITORING SITES | 1643 | ||
SUMMARY | 1644 | ||
References | 1645 | ||
References | 1646.e1 | ||
Chapter\r55 - Airway Management in the Adult | 1647 | ||
INTRODUCTION | 1648 | ||
FUNCTIONAL AIRWAY ANATOMY | 1648 | ||
AIRWAY ASSESSMENT | 1651 | ||
PHYSIOLOGIC CONCEPTS FOR AIRWAY MANAGEMENT | 1653 | ||
ANESTHESIA FOR AIRWAY MANAGEMENT | 1654 | ||
VENTILATION VIA A MASK | 1659 | ||
SUPRAGLOTTIC AIRWAY | 1661 | ||
ENDOTRACHEAL INTUBATION | 1665 | ||
PERCUTANEOUS AIRWAYS | 1678 | ||
EXTUBATION OF THE TRACHEA | 1680 | ||
SUMMARY | 1681 | ||
References | 1681 | ||
References | 1683.e1 | ||
Chapter\r56 - Spinal, Epidural, and Caudal Anesthesia | 1684 | ||
PRINCIPLES | 1684 | ||
PRACTICE | 1684 | ||
HISTORICAL PERSPECTIVES | 1685 | ||
ANATOMY | 1685 | ||
ANATOMIC VARIATIONS | 1687 | ||
MECHANISM OF ACTION | 1688 | ||
PHYSIOLOGIC EFFECTS | 1689 | ||
INDICATIONS | 1691 | ||
CONTRAINDICATIONS | 1691 | ||
SPINAL ANESTHESIA | 1693 | ||
EPIDURAL ANESTHESIA | 1703 | ||
COMBINED SPINAL-EPIDURAL | 1709 | ||
CAUDAL ANESTHESIA | 1710 | ||
COMPLICATIONS | 1711 | ||
OUTCOMES | 1716 | ||
RECENT ADVANCES | 1716 | ||
References | 1717 | ||
References | 1720.e1 | ||
Chapter\r57 - Peripheral Nerve Blocks | 1721 | ||
TECHNIQUES FOR LOCALIZING NEURAL STRUCTURES | 1722 | ||
UPPER EXTREMITY BLOCKS | 1724 | ||
BLOCKS OF THE THORAX AND ABDOMEN | 1732 | ||
LOWER EXTREMITY BLOCKS | 1736 | ||
CONTINUOUS CATHETER TECHNIQUES | 1748 | ||
CHOICE OF LOCAL ANESTHETIC | 1749 | ||
COMPLICATIONS | 1749 | ||
SUMMARY | 1750 | ||
References | 1751 | ||
References | 1751.e1 | ||
Chapter\r58 - Ultrasound Guidance for Regional Anesthesia | 1752 | ||
INTRODUCTION | 1752 | ||
FUNDAMENTAL ASSUMPTIONS AND ARTIFACTS IN ULTRASOUND IMAGING | 1752 | ||
TRANSDUCER SELECTION, MANIPULATION, AND MODES OF IMAGING | 1753 | ||
NEEDLE TIP VISIBILITY | 1756 | ||
APPROACHES TO REGIONAL BLOCK WITH ULTRASOUND | 1757 | ||
EXAMPLES OF COMMON REGIONAL BLOCKS | 1759 | ||
TRAINING AND SAFETY | 1764 | ||
CONCLUSIONS | 1765 | ||
References | 1766 | ||
References | 1766.e1 | ||
Chapter\r59 - Perioperative Fluid and Electrolyte Therapy | 1767 | ||
PHYSIOLOGY | 1768 | ||
References | 1808 | ||
References | 1810.e1 | ||
Chapter\r60 - Perioperative Acid-Base Balance | 1811 | ||
WHY IS ACID-BASE BALANCE IMPORTANT? | 1811 | ||
WHAT ARE ACIDS AND BASES? | 1811 | ||
ACID-BASE ABNORMALITIES | 1814 | ||
REGULATION OF ACID-BASE BALANCE | 1816 | ||
ANALYTIC TOOLS USED IN ACID-BASE CHEMISTRY | 1817 | ||
ACID-BASE PROBLEMS IN DIFFERENT CLINICAL SETTINGS | 1823 | ||
TREATING ACID-BASE DISTURBANCES | 1828 | ||
SUMMARY | 1829 | ||
References | 1829 | ||
References | 1829.e1 | ||
Chapter 61\r- Patient Blood Management: Transfusion Therapy | 1830 | ||
EVOLUTION AND RECENT HISTORY OF BLOOD TRANSFUSION THERAPY | 1830 | ||
1990 TO 2005 | 1831 | ||
INDICATIONS FOR TRANSFUSION | 1831 | ||
CHANGES DURING STORAGE OF BLOOD | 1835 | ||
COMPATIBILITY TESTING | 1837 | ||
APPROACHES REQUIRING LESS THAN A COMPLETE CROSSMATCH | 1839 | ||
EMERGENCY TRANSFUSION | 1840 | ||
COMPLICATIONS | 1842 | ||
TRANSFUSION RATIOS | 1848 | ||
BLOOD TRANSFUSIONS, PHARMACOLOGY, AND HEMOSTASIS | 1849 | ||
CITRATE INTOXICATION AND HYPERKALEMIA | 1850 | ||
TEMPERATURE | 1850 | ||
ACID-BASE ABNORMALITIES | 1851 | ||
TRANSFUSION REACTIONS | 1851 | ||
OTHER NONINFECTIOUS RISKS OF BLOOD TRANSFUSIONS | 1854 | ||
OTHER ADVERSE EFFECTS OF BLOOD TRANSFUSION | 1858 | ||
LEUKOREDUCTION AND IRRADIATION OF BLOOD TRANSFUSIONS | 1858 | ||
BLOOD COMPONENT THERAPY | 1859 | ||
ALBUMIN AND PLASMA PROTEIN PREPARATIONS | 1862 | ||
SYNTHETIC COLLOID SOLUTION THERAPY | 1863 | ||
SYNTHETIC OXYGEN-CARRYING SUBSTANCES | 1864 | ||
INFORMED CONSENT | 1865 | ||
References | 1865 | ||
References | 1867.e1 | ||
Chapter 62 - Patient Blood Management: Coagulation | 1868 | ||
NORMAL HEMOSTASIS | 1868 | ||
DISORDERS OF HEMOSTASIS | 1871 | ||
PROTHROMBOTIC STATES | 1874 | ||
MONITORING COAGULATION | 1876 | ||
References | 1880 | ||
References | 1880.e1 | ||
Chapter\r63 - Patient Blood Management: Autologous Blood Procurement, Recombinant Factor VIIa Therapy, and Blood Utilization | 1881 | ||
AUTOLOGOUS BLOOD PROCUREMENT | 1882 | ||
RECOMBINANT FACTOR VIIA | 1888 | ||
BLOOD UTILIZATION | 1890 | ||
BLOODLESS MEDICINE | 1894 | ||
CONCLUSION | 1895 | ||
References | 1895 | ||
References | 1896.e1 | ||
Index | i1 | ||
IBC | IBC | ||
Front\rCover | Cover | ||
IFC | IFC | ||
Miller’s Anesthesia | iii | ||
Copyright | iv | ||
Dedication | v | ||
Contributors | vi | ||
Preface | xxi | ||
Remembrance | xxiii | ||
Contents | xxv | ||
Video Contents | xxx | ||
PART V - Adult Subspecialty\rManagement | 1897 | ||
Chapter\r64 - Anesthesia and Treatment of Chronic Pain | 1898 | ||
PHYSIOLOGIC CHANGES IN PERSISTENT PAIN | 1898 | ||
CLINICAL DEFINITIONS, PREVALENCE, AND CLASSIFICATION OF CHRONIC PAIN | 1901 | ||
INTERDISCIPLINARY MANAGEMENT OF CHRONIC PAIN | 1902 | ||
DRUGS USED FOR CHRONIC PAIN | 1903 | ||
INTERVENTIONAL METHODS USED FOR CHRONIC PAIN | 1910 | ||
PERIOPERATIVE MANAGEMENT OF PATIENTS WITH CHRONIC PAIN | 1912 | ||
References | 1917 | ||
References | 1918.e1 | ||
Chapter\r65 - Palliative Medicine | 1919 | ||
WHAT IS PALLIATIVE MEDICINE? | 1919 | ||
WHERE IS PALLIATIVE CARE DELIVERED? | 1921 | ||
DIFFERENCES BETWEEN HOSPICE CARE AND PALLIATIVE CARE | 1923 | ||
COMMUNICATION | 1925 | ||
PROGNOSIS | 1928 | ||
DYING PROCESS | 1932 | ||
ANESTHETIC CONCERNS IN THE PATIENT RECEIVING PALLIATIVE CARE | 1938 | ||
References | 1940 | ||
References | 1941.e1 | ||
Chapter\r66 - Anesthesia for Thoracic Surgery | 1942 | ||
PREOPERATIVE EVALUATION OF THE THORACIC SURGERY PATIENT | 1943 | ||
CONCOMITANT MEDICAL CONDITIONS | 1945 | ||
ASSESSMENT OF THE PATIENT WITH LUNG CANCER (SEE CHAPTER 38) | 1951 | ||
DIFFICULT ENDOBRONCHIAL INTUBATION | 1952 | ||
PREDICTION OF DESATURATION DURING ONE-LUNG VENTILATION | 1953 | ||
ASSESSMENT FOR REPEAT THORACIC SURGERY | 1953 | ||
INTRAOPERATIVE MONITORING (SEE CHAPTERS 44 AND 51) | 1953 | ||
INVASIVE HEMODYNAMIC MONITORING (SEE CHAPTER 45) | 1954 | ||
OTHER NEW MONITORING TECHNOLOGY | 1955 | ||
LUNG ISOLATION | 1955 | ||
DIFFICULT AIRWAYS AND ONE-LUNG VENTILATION | 1962 | ||
LUNG ISOLATION TECHNIQUES IN PATIENTS WITH A TRACHEOSTOMY IN PLACE | 1963 | ||
ANESTHETIC MANAGEMENT | 1967 | ||
MANAGEMENT OF ONE-LUNG VENTILATION | 1967 | ||
HYPOXIC PULMONARY VASOCONSTRICTION | 1969 | ||
VENTILATION STRATEGIES DURING ONE-LUNG VENTILATION | 1970 | ||
PREDICTION OF HYPOXEMIA DURING ONE-LUNG VENTILATION | 1972 | ||
TREATMENT OF HYPOXEMIA DURING ONE-LUNG VENTILATION | 1973 | ||
ANESTHETIC MANAGEMENT FOR COMMON SURGICAL PROCEDURES | 1976 | ||
PULMONARY SURGERY | 1980 | ||
LOBECTOMY | 1981 | ||
PNEUMONECTOMY | 1982 | ||
LIMITED PULMONARY RESECTIONS: SEGMENTECTOMY AND WEDGE RESECTION | 1984 | ||
ANESTHETIC MANAGEMENT FOR SPECIFIC SURGICAL PROCEDURES | 1984 | ||
ANESTHESIA FOR TRACHEAL RESECTION | 1987 | ||
BLEBS, BULLAE, CYSTS, AND PNEUMATOCELES | 1991 | ||
LUNG TRANSPLANTATION | 1992 | ||
PULMONARY HEMORRHAGE | 1994 | ||
PULMONARY THROMBOENDARTERECTOMY | 1996 | ||
BRONCHOPULMONARY LAVAGE | 1996 | ||
MEDIASTINAL MASSES | 1997 | ||
THYMECTOMY FOR MYASTHENIA GRAVIS | 1998 | ||
POSTOPERATIVE MANAGEMENT | 1999 | ||
POSTOPERATIVE ANALGESIA (SEE CHAPTER 98) | 2000 | ||
References | 2004 | ||
References | 2006.e1 | ||
Chapter\r67 - Anesthesia for Cardiac Surgical Procedures | 2007 | ||
CARDIOVASCULAR DISEASE IN THE TWENTY-FIRST CENTURY | 2008 | ||
APPROACH TO ANESTHESIA FOR THE ADULT CARDIAC PATIENT | 2009 | ||
CARDIOPULMONARY BYPASS | 2032 | ||
SPECIFIC CARDIOVASCULAR DISEASE STATES | 2045 | ||
PROCEDURES IN THE CARDIAC CATHETERIZATION LABORATORY AND THE HYBRID OPERATING ROOM | 2077 | ||
PROBLEMS IN THE POSTOPERATIVE PERIOD | 2079 | ||
References | 2091 | ||
References | 2095.e1 | ||
Chapter\r68 - Anesthesia for Correction of Cardiac Arrhythmias | 2096 | ||
HISTORICAL PERSPECTIVES | 2096 | ||
SCOPE OF CARDIAC ARRHYTHMIAS | 2097 | ||
NORMAL CARDIAC RHYTHM | 2097 | ||
CARDIAC ARRHYTHMIAS | 2098 | ||
PERMANENT PACING | 2100 | ||
RESYNCHRONIZATION THERAPY | 2101 | ||
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | 2102 | ||
CORRECTION OF CARDIAC ARRHYTHMIAS WITH ABLATION THERAPY | 2103 | ||
FUTURE TRENDS | 2104 | ||
References | 2105 | ||
References | 2105.e1 | ||
Chapter 69 - Anesthesia for Vascular Surgery | 2106 | ||
ATHEROSCLEROSIS | 2107 | ||
PREOPERATIVE EVALUATION | 2108 | ||
PERIOPERATIVE MYOCARDIAL ISCHEMIA | 2114 | ||
PERIOPERATIVE Β-ADRENERGIC BLOCKER THERAPY | 2115 | ||
PERIOPERATIVE STATIN THERAPY | 2115 | ||
HEMODYNAMIC MONITORING | 2116 | ||
ABDOMINAL AORTIC RECONSTRUCTION | 2116 | ||
THORACOABDOMINAL AORTIC SURGERY | 2127 | ||
ENDOVASCULAR AORTIC REPAIR SURGERY | 2136 | ||
LOWER EXTREMITY REVASCULARIZATION | 2140 | ||
CAROTID ENDARTERECTOMY | 2147 | ||
POSTOPERATIVE MANAGEMENT OF VASCULAR SURGERY PATIENTS | 2155 | ||
References | 2156 | ||
References | 2157.e1 | ||
Chapter\r70 - Anesthesia for Neurologic Surgery | 2158 | ||
RECURRENT ISSUES IN NEUROANESTHESIA | 2159 | ||
SPECIFIC PROCEDURES | 2176 | ||
References | 2196 | ||
References | 2199.e1 | ||
Chapter\r71 - Anesthesia for Bariatric Surgery | 2200 | ||
OBESITY AS A DISEASE | 2200 | ||
NONSURGICAL MANAGEMENT OF OBESITY | 2204 | ||
SURGICAL MANAGEMENT OF OBESITY | 2206 | ||
ANESTHETIC MANAGEMENT OF THE BARIATRIC SURGICAL PATIENT | 2208 | ||
CONSIDERATIONS FOR MANAGEMENT OF THE OBESE PATIENT PRESENTING FOR NONBARIATRIC SURGERY | 2215 | ||
References | 2215 | ||
References | 2216.e1 | ||
Chapter\r72 - Anesthesia and the Renal and Genitourinary Systems | 2217 | ||
INNERVATION OF THE GENITOURINARY SYSTEM | 2218 | ||
ANESTHESIA FOR PATIENTS WITH RENAL DISEASE | 2220 | ||
RENAL AND GENITOURINARY PROCEDURES | 2229 | ||
UROGENITAL PAIN SYNDROMES | 2239 | ||
References | 2242 | ||
References | 2243.e1 | ||
Chapter\r73 - Anesthesia and the Hepatobiliary System | 2244 | ||
EFFECT OF ANESTHETICS ON HEPATIC FUNCTION | 2245 | ||
EFFECT OF HEPATIC DYSFUNCTION AND HEPATOBILIARY DISEASE ON ANESTHETIC DRUG PHARMACOKINETICS | 2248 | ||
RISK FACTORS FOR POSTOPERATIVE HEPATOBILIARY COMPLICATIONS | 2250 | ||
POSTOPERATIVE JAUNDICE | 2255 | ||
PERIOPERATIVE MANAGEMENT OF PATIENTS WITH ASYMPTOMATIC OR CHRONIC LIVER DYSFUNCTION | 2257 | ||
ANESTHETIC CONSIDERATIONS FOR PROCEDURES INVOLVING THE LIVER AND BILIARY SYSTEM | 2259 | ||
References | 2260 | ||
References | 2261.e1 | ||
Chapter\x0B74 - Anesthesia for Abdominal Organ Transplantation | 2262 | ||
ABDOMINAL ORGAN TRANSPLANTATION | 2262 | ||
KIDNEY TRANSPLANTATION | 2263 | ||
PANCREAS TRANSPLANTATION | 2270 | ||
LIVER TRANSPLANTATION | 2274 | ||
CONCLUSIONS | 2289 | ||
References | 2289 | ||
References | 2291.e1 | ||
Chapter\r75 - Anesthesia for Organ Procurement | 2292 | ||
INTRODUCTION | 2292 | ||
MANAGEMENT OF ORGAN DONORS AFTER DECLARATION OF BRAIN (NEUROLOGIC) DEATH | 2293 | ||
DIAGNOSIS AND DETERMINATION OF BRAIN DEATH | 2294 | ||
DONATION AFTER CARDIAC (CIRCULATORY) DEATH | 2295 | ||
ISCHEMIA-REPERFUSION INJURY AND ORGAN PRESERVATION | 2297 | ||
EXTENDED CRITERIA DONOR | 2298 | ||
MANAGEMENT OF ORGAN DONORS BEFORE PROCUREMENT | 2298 | ||
MANAGEMENT OF DONORS AFTER CARDIAC DEATH | 2300 | ||
MANAGEMENT OF ORGAN DONOR DURING PROCUREMENT SURGERY | 2301 | ||
MANAGEMENT OF LIVING ORGAN DONORS | 2301 | ||
References | 2305 | ||
References | 2306.e1 | ||
Chapter\r76 - Brain Death | 2307 | ||
INTRODUCTION | 2308 | ||
HISTORY | 2308 | ||
TRADITIONAL CONCEPT OF DEATH OF AN ORGANISM | 2311 | ||
THE CONCEPT OF BRAIN DEATH | 2312 | ||
MECHANISM OF BRAIN DEATH | 2313 | ||
NEUROPHYSIOLOGIC BASIS OF BRAIN DEATH | 2313 | ||
CRITERIA AND TESTS FOR DETERMINING BRAIN DEATH | 2317 | ||
PREREQUISITES FOR DIAGNOSING BRAIN DEATH | 2317 | ||
CLINICAL DIAGNOSIS OF BRAIN DEATH | 2318 | ||
SPECIAL CONSIDERATIONS | 2318 | ||
VARIABILITY IN POLICIES AND PRACTICES FOR DETERMINING BRAIN DEATH | 2319 | ||
ANCILLARY TESTS FOR BRAIN DEATH | 2320 | ||
ORGAN DONATION | 2324 | ||
References | 2326 | ||
References | 2327.e1 | ||
Chapter\r77 - Anesthesia for Obstetrics | 2328 | ||
PHYSIOLOGIC CHANGES DURING PREGNANCY AND DELIVERY | 2329 | ||
UTEROPLACENTAL PHYSIOLOGY | 2334 | ||
LABOR PROGRESS | 2335 | ||
LABOR AND FETAL MONITORING | 2337 | ||
LABOR ANALGESIA | 2339 | ||
ANESTHESIA CONSIDERATIONS FOR OPERATIVE DELIVERY | 2343 | ||
ANESTHESIA FOR CESAREAN DELIVERY | 2343 | ||
SPINAL ANESTHESIA | 2344 | ||
MATERNAL COMORBIDITIES | 2348 | ||
ANESTHESIA FOR ABNORMAL PRESENTATIONS | 2350 | ||
OBSTETRIC EMERGENCIES | 2350 | ||
NONOBSTETRIC SURGERY DURING PREGNANCY | 2353 | ||
References | 2356 | ||
References | 2358.e1 | ||
Chapter\r78 - Anesthesia for Fetal Surgery and Other Fetal Therapies | 2359 | ||
INDICATIONS, PROCEDURES, AND OUTCOMES | 2362 | ||
OBSTRUCTIVE UROPATHY | 2364 | ||
PREOPERATIVE ASSESSMENT AND COUNSELING | 2374 | ||
INTRAOPERATIVE MANAGEMENT AND CONSIDERATIONS | 2375 | ||
POSTOPERATIVE MANAGEMENT AND CONSIDERATIONS | 2380 | ||
MANAGEMENT OF EX UTERO INTRAPARTUM TREATMENT PROCEDURE | 2381 | ||
CONCLUSIONS AND FUTURE CONSIDERATIONS | 2383 | ||
References | 2383 | ||
References | 2385.e1 | ||
Chapter\r79 - Anesthesia for Orthopedic Surgery | 2386 | ||
PREOPERATIVE EVALUATION | 2386 | ||
REGIONAL VERSUS GENERAL ANESTHESIA | 2394 | ||
PERIOPERATIVE MANAGEMENT OF ORTHOPEDIC PATIENTS | 2394 | ||
References | 2405 | ||
References | 2406.e1 | ||
Chapter\r80 - Geriatric Anesthesia | 2407 | ||
CORE CONCEPTS IN THE ANESTHETIC MANAGEMENT OF THE OLDER PATIENT | 2408 | ||
COGNITIVE ISSUES IN OLDER ADULTS | 2412 | ||
CONSENT, SURROGATE DECISION MAKERS, AND ADVANCE DIRECTIVES | 2415 | ||
RISK ASSESSMENT AND PREOPERATIVE EVALUATION | 2415 | ||
SPECIAL PERIOPERATIVE CONSIDERATIONS FOR THE OLDER PATIENT | 2417 | ||
ANESTHETIC MANAGEMENT | 2417 | ||
OUTCOMES | 2420 | ||
References | 2420 | ||
References | 2422.e1 | ||
Chapter\r81 - Anesthesia for Trauma | 2423 | ||
PRIORITIZING TRAUMA CARE | 2425 | ||
ANESTHESIA IN WAR AND AUSTERE CONDITIONS | 2427 | ||
EMERGENCY AIRWAY MANAGEMENT | 2429 | ||
RESUSCITATION FROM HEMORRHAGIC SHOCK | 2433 | ||
RESUSCITATION FLUIDS | 2440 | ||
TRAUMA TO THE CENTRAL NERVOUS SYSTEM | 2443 | ||
ORTHOPEDIC AND SOFT TISSUE TRAUMA | 2450 | ||
OTHER TRAUMATIC INJURIES | 2452 | ||
SELECTED PATIENT POPULATIONS | 2455 | ||
POSTOPERATIVE CARE | 2456 | ||
SUMMARY | 2457 | ||
References | 2457 | ||
References | 2459.e1 | ||
Chapter\r82 - Anesthesia and Prehospital Emergency and Trauma Care | 2460 | ||
INTRODUCTION AND HISTORICAL BACKGROUND | 2460 | ||
ORGANIZATIONAL MODELS OF PREHOSPITAL EMERGENCY CARE | 2461 | ||
BASIC TECHNIQUES AND SKILLS | 2463 | ||
ADULT MEDICAL EMERGENCIES | 2468 | ||
PEDIATRIC EMERGENCIES | 2472 | ||
PREHOSPITAL MASS CASUALTY INCIDENT MANAGEMENT AND DISASTER MEDICINE | 2475 | ||
References | 2477 | ||
References for online | 2478.e1 | ||
CHAPTER\r83 - THE ROLE OF THE ANESTHESIA PROVIDER IN NATURAL AND HUMAN-INDUCED DISASTERS* | 2480 | ||
CLASSIFICATION | 2480 | ||
RESPONDING TO NATURAL DISASTER | 2480 | ||
THE IMPACT OF NATURAL DISASTER ON THE WORK OF THE ANESTHESIA PROVIDER | 2480 | ||
RESPONDING TO A NATURAL DISASTER: PRACTICAL CONSIDERATIONS | 2481 | ||
PREHOSPITAL ON-SITE EMERGENCY CARE | 2481 | ||
EARTHQUAKES: A SPECIAL DISASTER SITUATION | 2481 | ||
FIELD ANESTHESIA | 2483 | ||
ANESTHETIC TECHNIQUES FOR USE IN NATURAL DISASTERS | 2485 | ||
INTRODUCTION | 2487 | ||
APPROACHES TO THE LITERATURE | 2488 | ||
DEFINITIONS | 2488 | ||
ESSENTIAL PROPERTIES OF CHEMICAL AND BIOLOGIC WARFARE AGENTS | 2489 | ||
TOXICITY AND ITS MODIFICATIONS | 2489 | ||
AGENTS OF CHEMICAL AND BIOLOGIC WARFARE: BACKGROUND AND DEVELOPMENT | 2490 | ||
HAZARDS AND THREATS | 2492 | ||
MODES OF RELEASE OF CHEMICAL AND BIOLOGICAL WARFARE AGENTS | 2492 | ||
AGENTS | 2493 | ||
INVOLVEMENT OF THE ANESTHESIA PROVIDER IN THE MANAGEMENT OF CASUALTIES FROM EXPOSURE TO CHEMICAL AND BIOLOGIC WARFARE AGENTS | 2506 | ||
EFFECTS OF CHEMICAL AND BIOLOGIC WARFARE AGENTS ON ANESTHETIC PRACTICE | 2509 | ||
References | 2510 | ||
References | 2511.e1 | ||
Chapter\r84 - Anesthesia for Eye Surgery | 2512 | ||
OCULAR ANATOMY | 2512 | ||
OCULOCARDIAC REFLEX | 2513 | ||
INTRAOCULAR PRESSURE | 2513 | ||
OPHTHALMOLOGIC DRUGS | 2514 | ||
PREOPERATIVE EVALUATION (SEE CHAPTER 38) | 2514 | ||
ANESTHETIC TECHNIQUES | 2516 | ||
OPHTHALMOLOGIC PROCEDURES | 2518 | ||
References | 2521 | ||
References | 2522.e1 | ||
Chapter 85 - Anesthesia for Ear, Nose, and Throat Surgery | 2523 | ||
SYNOPSIS OF EAR, NOSE, AND THROAT ANATOMY | 2524 | ||
PREOPERATIVE EVALUATION FOR EAR, NOSE, AND THROAT SURGERY | 2526 | ||
AIRWAY MANAGEMENT IN OTOLARYNGOLOGY | 2527 | ||
AIRWAY DISORDERS IN OTOLARYNGOLOGY | 2528 | ||
ANESTHESIA FOR PANENDOSCOPY | 2530 | ||
OTOLARYNGOLOGIC TRAUMA | 2534 | ||
NASAL SURGERY | 2535 | ||
TONSILLECTOMY AND ADENOIDECTOMY | 2536 | ||
ENDOSCOPIC SINUS SURGERY | 2537 | ||
THYROID AND PARATHYROID SURGERY | 2537 | ||
AIRWAY FIRES | 2538 | ||
EAR SURGERY | 2538 | ||
PAROTID AND OTHER SALIVARY GLAND SURGERY | 2540 | ||
SLEEP APNEA SURGERY | 2540 | ||
ZENKER DIVERTICULUM | 2541 | ||
ANESTHESIA FOR SURGICAL AIRWAYS: CRICOTHYROTOMY AND TRACHEOSTOMY | 2542 | ||
NECK DISSECTION AND LARYNGECTOMY | 2542 | ||
MAXILLARY, MANDIBULAR, AND TEMPOROMANDIBULAR JOINT SURGERY | 2543 | ||
EAR, NOSE, AND THROAT LASER SURGERY | 2543 | ||
PHONOSURGERY | 2545 | ||
HEAD AND NECK FLAP RECONSTRUCTIVE SURGERY | 2545 | ||
STRIDOR AND HELIOX | 2546 | ||
ANESTHESIA FOR FACE TRANSPLANTATION | 2546 | ||
References | 2547 | ||
References | 2549.e1 | ||
Chapter 86 - Administration of Anesthesia by Robots | 2550 | ||
WHAT IS A ROBOT? | 2550 | ||
DECISION SUPPORT SYSTEMS FOR INTRAOPERATIVE USE IN ANESTHESIA | 2551 | ||
CLOSED-LOOP SYSTEMS | 2557 | ||
VARVEL PARAMETERS IN CONTROLLER PERFORMANCE EVALUATION | 2559 | ||
THE CLOSED-LOOP ANESTHESIA DELIVERY SYSTEM: PURI’S RESEARCH GROUP | 2563 | ||
THE WORK OF THE ITAG RESEARCH GROUP | 2568 | ||
REGULATORY ISSUES: WHY ARE CLOSED-LOOP SYSTEMS NOT YET COMMERCIALLY AVAILABLE? | 2575 | ||
MANUAL ROBOTS | 2577 | ||
References | 2579 | ||
References | 2580.e1 | ||
Chapter\r87 - Anesthesia for Robotically Conducted Surgery | 2581 | ||
HISTORY | 2582 | ||
ROBOTIC SYSTEMS | 2583 | ||
CARDIAC SURGERY (ALSO SEE CHAPTER 67) | 2586 | ||
ROBOTIC-ASSISTED THORACOSCOPIC SURGERY | 2592 | ||
UROLOGIC SURGERY | 2593 | ||
GENERAL SURGERY | 2594 | ||
ANESTHETIC CONSIDERATIONS | 2594 | ||
GYNECOLOGIC SURGERY | 2594 | ||
NEUROSURGERY | 2595 | ||
ORTHOPEDIC SURGERY | 2595 | ||
SUMMARY | 2596 | ||
References | 2596 | ||
References | 2597.e1 | ||
Chapter\r88 - Anesthesia for Laser Surgery | 2598 | ||
PHYSICS OF LASER | 2598 | ||
TYPES OF LASERS | 2599 | ||
LASER MODES AND SETTINGS | 2600 | ||
BIOLOGIC EFFECT | 2600 | ||
COMMON LASER OPERATIONS | 2601 | ||
RISKS OF LASER USE: STANDARDS AND REGULATIONS | 2601 | ||
SPECIFIC LASER HAZARDS | 2603 | ||
OPERATING ROOM FIRE | 2605 | ||
OTHER CONSIDERATIONS | 2610 | ||
AIRWAY AND OTHER FIRES ON THE SURFACE OF THE PATIENT | 2610 | ||
References | 2610 | ||
References | 2611.e1 | ||
Chapter\r89 - Ambulatory (Outpatient) Anesthesia | 2612 | ||
DEFINITIONS | 2613 | ||
BENEFITS OF AMBULATORY SURGERY | 2613 | ||
FACILITIES FOR AMBULATORY SURGERY | 2613 | ||
PATIENT SELECTION CRITERIA | 2614 | ||
PREOPERATIVE ASSESSMENT | 2617 | ||
PATIENT PREPARATION | 2619 | ||
ANESTHETIC TECHNIQUES | 2621 | ||
MONITORING DEPTH OF ANESTHESIA | 2631 | ||
RECOVERY FROM AMBULATORY ANESTHESIA | 2631 | ||
POSTOPERATIVE PAIN | 2633 | ||
POSTOPERATIVE NAUSEA AND VOMITING | 2634 | ||
SPECIAL AREAS | 2637 | ||
HOME READINESS AND BEYOND | 2639 | ||
References | 2641 | ||
References | 2645.e1 | ||
Chapter\r90 - Non–Operating Room Anesthesia | 2646 | ||
OVERVIEW: DEFINING NON–OPERATING ROOM ANESTHESIA—WHAT IT IS AND HOW WE GOT HERE | 2646 | ||
FINANCIAL AND OPERATIONAL CONSTRAINTS | 2648 | ||
TRANSITIONAL PRIORITIES FOR ANESTHESIOLOGISTS OUTSIDE OF THE OPERATING ROOM | 2650 | ||
GASTROINTESTINAL PROCEDURES IN THE ENDOSCOPY SUITE | 2653 | ||
INTERVENTIONAL PULMONARY PROCEDURES | 2655 | ||
NOVEL ANESTHETIC CONCERNS | 2655 | ||
ANESTHESIOLOGY FOR IMAGE-GUIDED INTERVENTIONS: EVOLUTION OF A NEW INTERFACE | 2655 | ||
PROCEDURES GUIDED BY COMPUTED TOMOGRAPHY, POSITRON EMISSION TOMOGRAPHY, AND MAGNETIC RESONANCE IMAGING | 2659 | ||
IMAGE-GUIDED PROCEDURES FOR SPECIALTY AREAS: NEURORADIOLOGY AND INTERVENTIONAL CARDIOLOGY | 2661 | ||
PROCEDURES IN THE NEURORADIOLOGY SUITE | 2661 | ||
INTERVENTIONAL CARDIOLOGY PROCEDURES: GENERAL CONSIDERATIONS FOR CATHERIZATION LABORATORY AND ELECTROPHYSIOLOGY LABORATORY | 2662 | ||
ANESTHESIOLOGISTS IN THE ELECTROPHYSIOLOGY LABORATORY | 2663 | ||
ANESTHESIOLOGISTS IN THE CATHERIZATION LABORATORY | 2665 | ||
INTERVENTIONAL ECHOCARDIOGRAPHY ANESTHESIOLOGISTS AS CO-PROCEDURALISTS—THE ROAD AHEAD | 2670 | ||
THE ROAD AHEAD: TOWARD A COMPREHENSIVE STRATEGY | 2670 | ||
References | 2672 | ||
References | 2673.e1 | ||
Chapter\r91 - Clinical Care in Extreme Environments: At High and Low Pressure and in Space | 2674 | ||
PHYSIOLOGIC EFFECTS OF INCREASED GAS PRESSURE | 2676 | ||
RATIONALE FOR THE TREATMENT OF SELECTED SPECIFIC SYNDROMES | 2679 | ||
FUTURE DIRECTIONS | 2682 | ||
THERAPEUTIC SYSTEMS | 2682 | ||
HYPERBARIC TREATMENT SCHEDULES | 2684 | ||
SIDE EFFECTS OF HYPERBARIC THERAPY | 2685 | ||
PRACTICAL ASPECTS OF HYPERBARIC THERAPY | 2687 | ||
EFFECTS OF ALTITUDE | 2692 | ||
MEDICAL CARE IN SPACE | 2699 | ||
SUMMARY | 2701 | ||
References | 2701 | ||
References | 2704.e1 | ||
PART VI -\rPediatric Anesthesia | 2705 | ||
Chapter\r92 - Regional Anesthesia in Children | 2706 | ||
RELEVANT DIFFERENCES BETWEEN CHILDREN AND ADULTS | 2706 | ||
INDICATIONS, CONTRAINDICATIONS, AND COMPLICATIONS | 2713 | ||
SELECTION OF MATERIALS AND ANESTHETIC SOLUTION | 2717 | ||
ANATOMIC IDENTIFICATION IN REGIONAL ANESTHESIA | 2719 | ||
SAFETY, PRECAUTIONS AND DISCHARGE CRITERIA | 2720 | ||
NEURAXIAL BLOCKS | 2722 | ||
UPPER EXTREMITY CONDUCTION BLOCKS | 2728 | ||
LOWER EXTREMITY CONDUCTION BLOCKS | 2736 | ||
BLOCKS OF NERVES SUPPLYING THE TRUNK | 2743 | ||
FACE, HEAD, AND NECK NERVE BLOCKS | 2748 | ||
OTHER PROCEDURES | 2753 | ||
References | 2754 | ||
References | 2756.e1 | ||
Chapter\r93 - Pediatric Anesthesia | 2757 | ||
DEVELOPMENTAL CONSIDERATIONS | 2758 | ||
PHARMACOLOGIC AND PHARMACODYNAMIC RESPONSES | 2763 | ||
ANESTHETIC CONSIDERATIONS | 2773 | ||
CONSIDERATIONS FOR NEONATAL ANESTHESIA | 2789 | ||
SPECIFIC NEONATAL AND SURGICAL PROCEDURES | 2791 | ||
REGIONAL ANESTHESIA AND ANALGESIA | 2796 | ||
References | 2796 | ||
References | 2798.e1 | ||
Chapter\r94 - Anesthesia for Pediatric Cardiac Surgery | 2799 | ||
UNIQUE FEATURES OF PEDIATRIC CARDIAC ANESTHESIA | 2800 | ||
ANESTHETIC MANAGEMENT | 2810 | ||
CARDIOPULMONARY BYPASS | 2819 | ||
ANTICOAGULATION, HEMOSTASIS, AND BLOOD CONSERVATION | 2832 | ||
POSTOPERATIVE MANAGEMENT | 2834 | ||
ANESTHESIA FOR HEART AND LUNG TRANSPLANTATION | 2837 | ||
ANESTHESIA FOR CLOSED-HEART OPERATIONS | 2840 | ||
ANESTHESIA FOR INTERVENTIONAL OR DIAGNOSTIC CARDIAC PROCEDURES | 2841 | ||
ADULT CONGENITAL HEART DISEASE | 2845 | ||
PEDIATRIC CARDIAC ELECTROPHYSIOLOGY | 2847 | ||
ADVANCES IN RESYNCHRONIZATION THERAPY | 2848 | ||
ANESTHESIA FOR NONCARDIAC SURGERY | 2849 | ||
OFFSITE ANESTHESIA IN CARDIAC SURGERY PATIENTS | 2850 | ||
References | 2851 | ||
References | 2853.e1 | ||
Chapter\r95 - Pediatric and Neonatal Intensive Care | 2854 | ||
RELATIONSHIP BETWEEN THE INTENSIVE CARE UNIT AND THE OPERATING ROOM | 2854 | ||
FAMILY PARTNERED CARE IN THE PEDIATRIC INTENSIVE CARE UNIT | 2855 | ||
DISCLOSURE OF MEDICAL ERRORS | 2855 | ||
ORGANIZATION OF THE PEDIATRIC INTENSIVE CARE UNIT | 2856 | ||
CARDIOVASCULAR SYSTEM (SEE ALSO CHAPTERS 93 AND 94) | 2856 | ||
COMMON CARDIOVASCULAR DISEASE STATES | 2857 | ||
CARDIOVASCULAR PHARMACOLOGY | 2861 | ||
NEONATAL RESUSCITATION | 2865 | ||
PHASES OF RESUSCITATION | 2869 | ||
INTERVENTIONS DURING THE CARDIAC ARREST (NO-FLOW) AND CPR (LOW-FLOW) | 2871 | ||
POSTRESUSCITATION MYOCARDIAL DYSFUNCTION | 2875 | ||
VENTRICULAR FIBRILLATION AND VENTRICULAR TACHYCARDIA IN CHILDREN | 2876 | ||
RESPIRATORY SYSTEM | 2877 | ||
CENTRAL NERVOUS SYSTEM | 2895 | ||
ENDOCRINE SYSTEM | 2905 | ||
GASTROINTESTINAL SYSTEM | 2906 | ||
IMMUNITY AND INFECTION | 2913 | ||
PEDIATRIC TRAUMA | 2915 | ||
TRANSPORT OF THE CRITICALLY ILL CHILD | 2917 | ||
References | 2917 | ||
References for online only | 2922.e1 | ||
PART VII\r- Postoperative Care | 2923 | ||
Chapter\r96 - The Postanesthesia Care Unit | 2924 | ||
ADMISSION TO THE PACU | 2925 | ||
STANDARDS FOR POSTANESTHESIA CARE | 2925 | ||
EARLY POSTOPERATIVE PHYSIOLOGIC CHANGES | 2926 | ||
TRANSPORT TO THE PACU | 2927 | ||
UPPER AIRWAY OBSTRUCTION | 2927 | ||
MANAGEMENT OF UPPER AIRWAY OBSTRUCTION | 2929 | ||
DIFFERENTIAL DIAGNOSIS OF ARTERIAL HYPOXEMIA IN THE PACU | 2930 | ||
PULMONARY EDEMA | 2931 | ||
MONITORING AND TREATMENT OF HYPOXEMIA | 2932 | ||
OPTIMAL PERIOPERATIVE OXYGENATION | 2932 | ||
OXYGEN DELIVERY SYSTEMS | 2933 | ||
HEMODYNAMIC INSTABILITY | 2935 | ||
MYOCARDIAL ISCHEMIA: EVALUATION AND TREATMENT | 2936 | ||
CARDIAC DYSRHYTHMIAS | 2937 | ||
RENAL DYSFUNCTION | 2938 | ||
BODY TEMPERATURE AND SHIVERING | 2939 | ||
POSTOPERATIVE NAUSEA AND VOMITING | 2940 | ||
DELIRIUM | 2940 | ||
EMERGENCE EXCITEMENT | 2941 | ||
DELAYED AWAKENING | 2941 | ||
DISCHARGE CRITERIA | 2942 | ||
INFECTION CONTROL | 2943 | ||
FUTURE CONSIDERATIONS | 2943 | ||
SUMMARY | 2944 | ||
References | 2945 | ||
References | 2946.e1 | ||
Chapter\r97 - Postoperative Nausea and Vomiting | 2947 | ||
ETIOLOGY: PATHWAYS FOR NAUSEA AND VOMITING | 2948 | ||
RISK FACTORS AND INDEPENDENT PREDICTORS | 2949 | ||
PROPHYLACTIC ANTIEMETIC STRATEGIES | 2958 | ||
ANTIEMETICS | 2963 | ||
SPECIAL SETTINGS | 2969 | ||
A RATIONAL GUIDELINE FOR THE MANAGEMENT OF POSTOPERATIVE NAUSEA AND VOMITING | 2970 | ||
References | 2972 | ||
References | 2973.e1 | ||
Chapter\r98 - Acute Postoperative Pain | 2974 | ||
FUNDAMENTAL CONSIDERATIONS | 2975 | ||
TREATMENT METHODS | 2978 | ||
SYSTEMIC ANALGESIC TECHNIQUES | 2978 | ||
POSTOPERATIVE ANALGESIA IN SPECIAL POPULATIONS | 2991 | ||
References | 2996 | ||
References | 2998.e1 | ||
Chapter\r99 - Cognitive Dysfunction and Other Long-term Complications of Surgery and Anesthesia | 2999 | ||
DETECTION OF POSTOPERATIVE COGNITIVE DYSFUNCTION | 3000 | ||
INCIDENCE AND RISK FACTORS FOR POSTOPERATIVE COGNITIVE DYSFUNCTION AFTER CARDIAC SURGERY | 3002 | ||
INCIDENCE AND RISK FACTORS FOR POSTOPERATIVE COGNITIVE DYSFUNCTION AFTER NONCARDIAC SURGERY | 3003 | ||
ETIOLOGIC CONSIDERATIONS | 3007 | ||
CLINICAL SIGNIFICANCE AND LONG-TERM CONSEQUENCES OF POSTOPERATIVE COGNITIVE DYSFUNCTION | 3009 | ||
References | 3009 | ||
References | 3010.e1 | ||
Chapter\r100 - Postoperative Visual Loss | 3011 | ||
RETINAL ISCHEMIA: BRANCH AND CENTRAL RETINAL ARTERY OCCLUSION | 3012 | ||
ISCHEMIC OPTIC NEUROPATHY | 3016 | ||
CORTICAL BLINDNESS | 3026 | ||
ACUTE GLAUCOMA | 3028 | ||
VISUAL CHANGES AFTER TRANSURETHRAL RESECTION OF THE PROSTATE | 3028 | ||
VISUAL LOSS AFTER VITRECTOMY AND VITREAL GAS BUBBLE TAMPONADE | 3029 | ||
CONCLUSION | 3029 | ||
References | 3029 | ||
References | 3032.e1 | ||
PART VIII -\rCritical Care Medicine | 3033 | ||
Chapter\r101 - Critical Care Anesthesiology | 3034 | ||
INTENSIVE CARE UNIT ORGANIZATION | 3034 | ||
QUALITY MEASUREMENT IN CRITICAL CARE | 3037 | ||
MANAGEMENT OF CRITICALLY ILL PATIENTS | 3038 | ||
COMPLICATIONS OF INTENSIVE CARE UNIT MANAGEMENT | 3048 | ||
CONCLUSION | 3051 | ||
References | 3051 | ||
References | 3053.e1 | ||
Chapter\r102 - Critical Care Protocols and Decision Support | 3054 | ||
RATIONALE FOR PROTOCOL DEVELOPMENT | 3055 | ||
PROTOCOL DESIGN | 3056 | ||
PROTOCOL IMPLEMENTATION | 3058 | ||
INTENSIVE CARE UNIT PROTOCOLS | 3058 | ||
THE FUTURE OF MEDICINE BASED ON PROTOCOLS | 3060 | ||
CONCLUSION | 3061 | ||
References | 3061 | ||
References | 3062.e1 | ||
Chapter\r103 - Respiratory Care | 3063 | ||
SETTINGS OF MECHANICAL VENTILATION | 3064 | ||
PRINCIPLES OF RESPIRATORY PHYSIOLOGY APPLICABLE TO THE CLINICAL SCENARIO | 3074 | ||
MECHANICAL VENTILATION IN THE CLINICAL SCENARIO | 3078 | ||
References | 3082 | ||
References | 3083.e1 | ||
Chapter\r104 - Nitric Oxide and Other Inhaled Pulmonary Vasodilators | 3084 | ||
INTRODUCTION | 3085 | ||
INHALED NITRIC OXIDE | 3085 | ||
OTHER INHALED PULMONARY VASODILATORS | 3095 | ||
CONCLUSIONS | 3096 | ||
References | 3096 | ||
References | 3097.e1 | ||
Chapter\r105 - Neurocritical Care | 3098 | ||
INTRACRANIAL PHYSIOLOGY AND CEREBRAL AUTOREGULATION | 3099 | ||
GENERAL CARDIOPULMONARY CONSIDERATIONS | 3101 | ||
FLUIDS AND ELECTROLYTES | 3102 | ||
FEVER AND INFECTION | 3103 | ||
MONITORING | 3103 | ||
COMMON DISEASES IN THE NEUROCRITICAL CARE UNIT | 3108 | ||
ETHICAL CONSIDERATIONS | 3118 | ||
CONCLUSION | 3118 | ||
References | 3118 | ||
References | 3120.e1 | ||
Chapter\r106 - Nutrition and Metabolomics | 3121 | ||
SYSTEMS BIOLOGY AND METABOLOMICS | 3121 | ||
METABOLIC CONTROL SYSTEMS AND THE RESPONSE TO SURGICAL STRESS | 3122 | ||
FASTING AND MALNUTRITION | 3132 | ||
EATING | 3133 | ||
METABOLIC RESPONSES TO SURGICAL AND TRAUMATIC INJURY | 3133 | ||
METABOLIC RESPONSES TO SEPSIS | 3138 | ||
MODULATING THE STRESS RESPONSE | 3139 | ||
NUTRITIONAL SUPPORT | 3144 | ||
SPECIAL CONSIDERATIONS | 3153 | ||
CONCLUSIONS | 3154 | ||
References | 3154 | ||
References | 3157.e1 | ||
Chapter\r107 - Extracorporeal Support Therapies | 3158 | ||
INTRODUCTION TO EXTRACORPOREAL SUPPORT THERAPIES: MULTIORGAN SUPPORT FOR THE PATIENT WHO IS CRITICALLY ILL | 3158 | ||
HISTORICAL NOTES | 3159 | ||
TECHNICAL ASPECTS AND MODES OF EXTRACORPOREAL SUPPORT | 3161 | ||
CLINICAL APPLICATIONS | 3173 | ||
ALTERNATIVE EXTRACORPOREAL SUPPORT TECHNIQUES | 3178 | ||
CONCLUSIONS | 3180 | ||
References | 3180 | ||
References | 3181.e1 | ||
Chapter\r108 - Cardiopulmonary Resuscitation: Basic and Advanced Life Support | 3182 | ||
SUDDEN CARDIAC ARREST AND CARDIOPULMONARY RESUSCITATION | 3183 | ||
MANAGEMENT OF CARDIAC ARREST | 3200 | ||
POSTRESUSCITATION INTERVENTIONS | 3203 | ||
PEDIATRIC RESUSCITATION | 3206 | ||
FUTURE OF RESUSCITATION SCIENCE AND CARE | 3213 | ||
References | 3214 | ||
References | 3216.e1 | ||
PART IX -\rAncillary Issues andResponsibilities | 3217 | ||
Chapter\r109 - Electrical Safety in the Operating Room | 3218 | ||
ELECTRICAL GROUND | 3220 | ||
ISOLATION OF ELECTRIC POWER FROM THE GROUND | 3221 | ||
CAPACITIVE COUPLING | 3224 | ||
ELECTRICAL SHOCK | 3226 | ||
ELECTROSURGERY | 3227 | ||
SAFE PRACTICE | 3229 | ||
References | 3230 | ||
References | 3230.e1 | ||
Chapter\r110 - Environmental Safety and Chemical Dependency | 3231 | ||
ANESTHESIA GASES | 3232 | ||
RADIATION | 3234 | ||
INFECTIONS | 3235 | ||
FATIGUE | 3239 | ||
SUBSTANCE ABUSE | 3240 | ||
TREATMENT | 3243 | ||
References | 3245 | ||
References | 3246.e1 | ||
Chapter\r111 - Statistical Methods in Anesthesia | 3247 | ||
STATISTICAL APPROACHES | 3248 | ||
STUDY DESIGN | 3252 | ||
EVIDENCE-BASED MEDICINE | 3256 | ||
SUMMARY | 3256 | ||
Bibliography | 3256 | ||
Chapter 112 - Evaluation and Classification of Evidence for the ASA Clinical Practice Guidelines | 3257 | ||
COLLECTION AND ORGANIZATIONOF LITERATURE | 3257 | ||
LITERATURE EVALUATIONAND MITIGATION OF BIAS | 3257 | ||
AGGREGATION AND CLASSIFICATIONOF LITERATURE-BASED EVIDENCE | 3264 | ||
EVALUATION OF OPINION-BASEDEVIDENCE | 3264 | ||
PROTOCOL FOR ORGANIZING ANDINTEGRATING AGGREGATED EVIDENCE | 3268 | ||
SUMMARY AND CONCLUSIONS | 3269 | ||
References | 3270 | ||
References | 3270.e1 | ||
Index | i1 | ||
IBC | IBC |